{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:30:47Z","timestamp":1786570247265,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacasi.2026.06.028","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:17:21Z","timestamp":1786493841000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Remodeling Trajectory and Renal Stage\u2013Specific Risk Stratification in East Asian Fabry Disease Patients"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9116-3520","authenticated-orcid":false,"given":"Yanjia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-2109","authenticated-orcid":false,"given":"Wei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2026.06.028_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease","volume":"77","author":"Pieroni","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010687","article-title":"Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine","volume":"16","author":"Monda","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.028_bib3","doi-asserted-by":"crossref","DOI":"10.15420\/cfr.2023.06","article-title":"Cardiovascular involvement in Fabry\u2019s disease: new advances in diagnostic strategies, outcome prediction and management","volume":"9","author":"Monda","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jacasi.2026.06.028_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2215\/CJN.09480819","article-title":"The changing landscape of Fabry disease","volume":"15","author":"Svarstad","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib5","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/s41436-019-0436-y","article-title":"Fabry disease cardiac variant IVS4+919 G>A is associated with multiple cardiac gene variants in patients with severe cardiomyopathy and fatal arrhythmia","volume":"21","author":"Juang","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jacasi.2026.06.028_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2023.04.016","article-title":"Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease","volume":"382","author":"Hiestand","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2023.07.026","article-title":"Prognostic implications of the extent of cardiac damage in patients with Fabry disease","volume":"82","author":"Meucci","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2215\/CJN.0000000000000239","article-title":"Early risk stratification for natural disease course in Fabry patients using plasma globotriaosylsphingosine levels","volume":"18","author":"Van Der Veen","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib9","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/heartjnl-2023-323783","article-title":"Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease","volume":"110","author":"Monda","year":"2024","journal-title":"Heart"},{"key":"10.1016\/j.jacasi.2026.06.028_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.gene.2018.11.054","article-title":"High incidence of co-existing factors significantly modifying the phenotype in patients with Fabry disease","volume":"687","author":"Koca","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.jacasi.2026.06.028_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ckj\/sfw082","article-title":"FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease","volume":"9","author":"Mignani","year":"2016","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacasi.2026.06.028_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2019.12.010","article-title":"FAbry STabilization indEX (FASTEX): clinical evaluation of disease progression in Fabry patients","volume":"129","author":"Lenders","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacasi.2026.06.028_bib13","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2026.06.028_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfad164","article-title":"Interpretation of GFR slope in untreated and treated adult Fabry patients","volume":"39","author":"Pisani","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacasi.2026.06.028_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2022.06.022","article-title":"Validated model for prediction of adverse cardiac outcome in patients with Fabry disease","volume":"80","author":"Orsborne","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2026.06.028_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005220","article-title":"Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy","volume":"11","author":"Verdonschot","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacasi.2026.06.028_bib17","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/eurheartj\/ehae148","article-title":"Anderson\u2013Fabry disease management: role of the cardiologist","volume":"45","author":"Pieroni","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2026.06.028_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726005284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374726005284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:01:10Z","timestamp":1786568470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374726005284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S2772374726005284"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.06.028","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Remodeling Trajectory and Renal Stage\u2013Specific Risk Stratification in East Asian Fabry Disease Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2026.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}